One case of intrahepatic cholangiocarcinoma amenable to resection after radioembolization

World Journal of Gastroenterology

Volumn 20, Issue 17, 2014, Pages 5131-5134

  Servajean, Cecilia ^a   Gilabert, Marine ^a   Piana, Gilles ^a   Monges, Geneviève ^a   Delpero, Jean Robert ^a   Brenot, Isabelle ^a   Raoul, Jean Luc ^a  

^a INSTITUT PAOLI CALMETTES   (France)

Author keywords

Combined treatments; Intrahepatic cholangiocarcinomal; Radioembolization; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; FOLOFIRINOX; GEMCITABINE; MICROSPHERE Y 90; OXALIPLATIN; RADIOACTIVE MICROSPHERE; SIRS SPHERE; UNCLASSIFIED DRUG; YTTRIUM 90; RADIOPHARMACEUTICAL AGENT;

ADULT; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; BILE DUCT CARCINOMA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER RESECTION; MALE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOEMBOLIZATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; BILE DUCT NEOPLASMS; BIOPSY; CHOLANGIOCARCINOMA; INTRAHEPATIC BILE DUCT; PROCEDURES; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOPSY; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; EMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84899872780     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i17.5131     Document Type: Article

References (11)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-1314 [PMID: 16214602 DOI: 10.1016/S0140-6736(05)67530-7]
2. Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 2008; 48: 308-321 [PMID: 18536057 DOI: 10.1002/hep.22310]
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol VIII. Lyon: IARC Press, 2002: 155
4. Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol 2004; 40: 472-477 [PMID: 15123362 DOI: 10.1016/j.jhep.2003.11.030]
5. Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, Pinna A, Dvorchik I, Fung JJ, Starzl TE. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997; 185: 429-436 [PMID: 9358085]
6. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J; ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010; 362: 1273-1281 [PMID: 20375404 DOI: 10.1056/NEJMoa0908721]
7. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option. Ann Surg Oncol 2010; 17: 484-491 [PMID: 19876691 DOI: 10.1245/s10434-009-0777-x]
8. Hyder O, Marsh JW, Salem R, Petre EN, Kalva S, Liapi E, Cosgrove D, Neal D, Kamel I, Zhu AX, Sofocleous CT, Geschwind JF, Pawlik TM. Intra-arterial therapy for advanced intrahepatic cholangiocarcinoma: a multi-institutional analysis. Ann Surg Oncol 2013; 20: 3779-3786 [PMID: 23846786]
9. Rafi S, Piduru SM, El-Rayes B, Kauh JS, Kooby DA, Sarmiento JM, Kim HS. Yttrium-90 radioembolization for unresectable standard-chemorefractory intrahepatic cholangiocarcinoma: survival, efficacy, and safety study. Cardiovasc Intervent Radiol 2013; 36: 440-448 [PMID: 22956045 DOI: 10.1007/s00270-012-0463-4]
10. Mouli S, Memon K, Baker T, Benson AB, Mulcahy MF, Gupta R, Ryu RK, Salem R, Lewandowski RJ. Yttrium-90 radioembolization for intrahepatic cholangiocarcinoma: safety, response, and survival analysis. J Vasc Interv Radiol 2013; 24: 1227-1234 [PMID: 23602420 DOI: 10.1016/j.jvir.2013.02.031]
11. Edeline J, Lenoir L, Boudjema K, Rolland Y, Boulic A, Le Du F, Pracht M, Raoul JL, Clément B, Garin E, Boucher E. Volumetric changes after (90)y radioembolization for hepatocellular carcinoma in cirrhosis: an option to portal vein embolization in a preoperative setting? Ann Surg Oncol 2013; 20: 2518-2525 [PMID: 23494107 DOI: 10.1245/s10434-013-2906-9]